DRMA

Healthcare Biotechnology

Dermata Therapeutics, Inc.

$1.11

-0.00 -0.45% today

Price History

Not enough data

Key Stats

Market Cap

5.48M

Avg Volume

710,643

EPS

-$4.39

52W High

$5.87

52W Low

$0.95

Div. Yield

0.0%

Analyst Ratings

Strong Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-0.29

P/B Ratio

1.27

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(183.9%)

Return on Assets

(89.9%)

Liquidity & Leverage

Current Ratio

2.81

Quick Ratio

2.41

Total Cash

4.41M

Total Debt

About

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.